Thailand
Croda Thailand was formed in 2007, providing sales, technical support, customer service and financial roles to local customers.
The team prides itself on creating a “fun”, lively, stimulating and exciting place to work, and all employees are encouraged to support the community through the Croda 1% Club.
16th Floor, Unit 13-14, Payathai Road
Patumwan
Bangkok
Thailand
10330
Tel: +66 2 160 5444
The team prides itself on creating a “fun”, lively, stimulating and exciting place to work, and all employees are encouraged to support the community through the Croda 1% Club.
Croda Thailand Co., Ltd
319 Chamchuri Square Building16th Floor, Unit 13-14, Payathai Road
Patumwan
Bangkok
Thailand
10330
Tel: +66 2 160 5444
Iberchem Thailand Ltd.
No. 41/87 Moo 6 Bangna Trad Road Km.16.5
Bangcha long-Sub District
Bangplee District
10540 Bangkok
Samutprakarn Province
Thailand
T +66 21307961
About us
We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.
Where we operate
Every day our global team, across 37 countries, work together to inspire our customers.
Further reading
Sustainability expert Aris Vrettos joins Croda
The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Croda joins the World Business Council for Sustainable Development
Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today joined over 200 of the world’s leading sustainable...
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines